Shanghai Haohai Biological Technology Co., Ltd. (688366.SS)

61,68 -0,42 (-0,68 %) À la clôture : 03:00PM CST

Shanghai Haohai Biological Technology Co., Ltd.

WenGuang Plaza
23rd Floor No. 1386, Hongqiao Road Changning District
Shanghai
China
86 21 5229 3555
https://www.3healthcare.com

Secteur(s): Healthcare
Secteur d’activité: Biotechnology
Employés à temps plein: 2 158

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Dr. Yongtai Hou	Executive Chairman	S.O.	S.O.	1962
Dr. Jianying Wu	GM & Executive Director	S.O.	S.O.	1964
Mr. Minjie Tang	CFO & Executive Director	S.O.	S.O.	1975
Ms. Yiyi Chen	Executive Director	S.O.	S.O.	1982
Ms. Min Tian	Joint Company Secretary	S.O.	S.O.	1989
Ms. Caixia Ren	Deputy General Manager	S.O.	S.O.	1958
Mr. Ming King Chiu FCIS, FCS	Joint Company Secretary	S.O.	S.O.	1977

Les montants ont été établis en date du et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en CNY.

Description

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. The company offers ophthalmology products consisting intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. It also offers sodium hyaluronate injection, medical chitosan, sodium hyaluronate gel, sodium hyaluronate gel, anti adhesion, and burn wound related products. In addition, the company provides injectors, scalpels, and suture needles. Further, it offers medical aesthetics products comprising Matrifill, a first-generation hyaluronic acid (HA) dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; genetic-engineering preparations for epidermal repair; and radio frequency devices and laser equipment. Additionally, the company is involved in the research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; sale of professional life and home cosmetology machines; and manufacture and sale of biological reagents, biologicals and biological materials, and other machines and accessories. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Shanghai Haohai Biological Technology Co., Ltd. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.